ALX Oncology (ALXO) Competitors $1.65 -0.01 (-0.60%) Closing price 10/16/2025 04:00 PM EasternExtended Trading$1.60 -0.04 (-2.73%) As of 10/16/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALXO vs. PRTC, SLDB, ADCT, UPXI, KRRO, AUTL, ATXS, EOLS, ALMS, and ETHZShould you be buying ALX Oncology stock or one of its competitors? The main competitors of ALX Oncology include PureTech Health (PRTC), Solid Biosciences (SLDB), ADC Therapeutics (ADCT), Upexi (UPXI), Korro Bio (KRRO), Autolus Therapeutics (AUTL), Astria Therapeutics (ATXS), Evolus (EOLS), Alumis (ALMS), and Flag Ship Acquisition (ETHZ). These companies are all part of the "pharmaceutical products" industry. ALX Oncology vs. Its Competitors PureTech Health Solid Biosciences ADC Therapeutics Upexi Korro Bio Autolus Therapeutics Astria Therapeutics Evolus Alumis Flag Ship Acquisition PureTech Health (NASDAQ:PRTC) and ALX Oncology (NASDAQ:ALXO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends. Which has more risk and volatility, PRTC or ALXO? PureTech Health has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500. Comparatively, ALX Oncology has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. Does the media favor PRTC or ALXO? In the previous week, PureTech Health had 3 more articles in the media than ALX Oncology. MarketBeat recorded 3 mentions for PureTech Health and 0 mentions for ALX Oncology. ALX Oncology's average media sentiment score of 1.89 beat PureTech Health's score of 0.30 indicating that ALX Oncology is being referred to more favorably in the news media. Company Overall Sentiment PureTech Health Neutral ALX Oncology Very Positive Do analysts rate PRTC or ALXO? ALX Oncology has a consensus target price of $3.30, suggesting a potential upside of 100.00%. Given ALX Oncology's stronger consensus rating and higher possible upside, analysts clearly believe ALX Oncology is more favorable than PureTech Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PureTech Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00ALX Oncology 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57 Do insiders & institutionals hold more shares of PRTC or ALXO? 0.0% of PureTech Health shares are held by institutional investors. Comparatively, 98.0% of ALX Oncology shares are held by institutional investors. 5.3% of PureTech Health shares are held by company insiders. Comparatively, 21.0% of ALX Oncology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is PRTC or ALXO more profitable? PureTech Health's return on equity of 0.00% beat ALX Oncology's return on equity.Company Net Margins Return on Equity Return on Assets PureTech HealthN/A N/A N/A ALX Oncology N/A -115.67%-84.82% Which has stronger earnings & valuation, PRTC or ALXO? PureTech Health has higher revenue and earnings than ALX Oncology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPureTech Health$4.83M86.22$27.78MN/AN/AALX OncologyN/AN/A-$134.85M-$2.20-0.75 SummaryALX Oncology beats PureTech Health on 7 of the 12 factors compared between the two stocks. Get ALX Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ALXO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALXO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALXO vs. The Competition Export to ExcelMetricALX OncologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$88.89M$3.41B$6.09B$10.55BDividend YieldN/A2.29%5.73%4.78%P/E Ratio-0.7522.9385.0827.19Price / SalesN/A486.15604.99132.96Price / CashN/A46.9737.8662.13Price / Book0.7710.5012.396.65Net Income-$134.85M-$52.47M$3.32B$276.79M7 Day Performance0.61%2.90%2.31%1.75%1 Month Performance57.14%15.36%9.69%5.15%1 Year Performance9.27%14.29%73.82%36.96% ALX Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALXOALX Oncology3.9789 of 5 stars$1.65-0.6%$3.30+100.0%+5.8%$88.89MN/A-0.7540Gap UpPRTCPureTech Health0.2146 of 5 stars$18.76-1.7%N/A-14.4%$461.13M$4.83M0.00100Short Interest ↑Gap DownSLDBSolid Biosciences2.9565 of 5 stars$5.48-7.1%$15.00+173.7%-12.1%$459.43M$8.09M-1.96100ADCTADC Therapeutics2.256 of 5 stars$4.43+8.6%$7.75+74.9%+29.2%$459M$70.84M-2.82310News CoverageAnalyst ForecastGap UpHigh Trading VolumeUPXIUpexi2.2952 of 5 stars$7.70+3.5%$15.50+101.3%+121.7%$438.13M$15.81M0.00130Analyst ForecastKRROKorro Bio2.2417 of 5 stars$43.70-5.5%$86.83+98.7%-36.9%$434.05M$2.27M-4.4870News CoverageAnalyst ForecastAUTLAutolus Therapeutics3.3066 of 5 stars$1.56-3.1%$9.12+484.6%-62.7%$428.49M$10.12M-1.86330Positive NewsATXSAstria Therapeutics2.0766 of 5 stars$7.69+2.3%$29.50+283.6%+4.6%$424.39MN/A-3.8330Trending NewsAnalyst DowngradeEOLSEvolus3.9382 of 5 stars$6.43-1.1%$21.25+230.5%-63.9%$420.45M$277.94M-6.56170Analyst ForecastALMSAlumis3.4368 of 5 stars$4.12+2.5%$20.17+389.5%-58.8%$418.34MN/A0.00N/APositive NewsETHZFlag Ship AcquisitionN/A$2.55+0.8%N/AN/A$416.01MN/A-0.177News CoverageStock Split Related Companies and Tools Related Companies PureTech Health Competitors Solid Biosciences Competitors ADC Therapeutics Competitors Upexi Competitors Korro Bio Competitors Autolus Therapeutics Competitors Astria Therapeutics Competitors Evolus Competitors Alumis Competitors Flag Ship Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALXO) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
